Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
SAN DIEGO, March 31, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's decision to fast-track the development of its...
-
Highlights: Fantom™ scaffold family, a significant product advance over ReZolve® technology Fast-track development of Fantom "thin-strut" fully bioresorbable...
-
REVA to Hold Briefing Call on Financial Results for 2013 and Present at Cowen Health Care Conference
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through December 31, 2013,...
-
SAN DIEGO, Feb. 23, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that Dr. Alexandre Abizaid, co-principal investigator for REVA's RESTORE II...
-
SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that David M. Eisler, Esq., has joined the Company's executive team as Vice...
-
SAN DIEGO, Jan. 13, 2014 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that it has completed enrollment in the clinical trial of the ReZolve2...
-
SAN DIEGO, Nov. 5, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through September 30, 2013 and...
-
SAN DIEGO, Oct. 30, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announces that in conjunction with Transcatheter Cardiovascular Therapeutics 2013 ("TCT"), which is...
-
SAN DIEGO, Oct. 28, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") announced initial clinical results from patients treated with its ReZolve2 sirolimus-eluting...
-
SAN DIEGO, Aug. 6, 2013 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") will hold a conference call to discuss the Company's financial results through June 30, 2013 and its...